Clinuvel Pharmaceuticals Ltd has released a press release.
CLINUVEL progresses innovative DNA Repair Program
Filed with ASX ·
Watch Clinuvel Pharmaceuticals' latest callClinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call · Replay · Aug 27Read the transcript of Clinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Clinuvel Pharmaceuticals Limited on 6ix
Earlier from Clinuvel Pharmaceuticals
- Corporate Presentation - 2020 Full Year Results
- CLINUVEL Declares Full Year Dividend
- CLINUVEL Full Year Results
- CLINUVEL Corporate Update
- Media Release - SCENESSE to be prescribed in China
Later from Clinuvel Pharmaceuticals
- Media Release - First patient dosed in SCENESSE DNA Repair
- Trading Halt
- Australian TGA approves SCENESSE
- Media Release - CLINUVEL to Trial Innovative Drug in Stroke
- CLINUVEL Strategic Update - Extended
Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.
Follow Clinuvel Pharmaceuticals